Not finding it? Sign in to also search OpenAlex live.
-
Nationwide strategies and outcomes of minimally invasive versus open combined liver ablation and resection for colorectal liver metastases2026 European Journal of Surgical Oncology article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Gabriela Pilz da Cunha, Ketharan Balasupramaniam, Niels Kok, Cornelis Kees Verhoef, Paul D. Gobardhan, Eric R. Manusama, +32 more
0citations -
Laparoscopic versus open parenchymal preserving liver resections in the posterosuperior segments (ORANGE Segments): a multicentre, single-blind, randomised controlled trial2025 The Lancet Regional Health - Europe article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Jasper P. Sijberden, Christoph Kuemmerli, Francesca Ratti, Mathieu D’Hondt, Robert Peter Sutcliffe, Roberto Ivan TROISI, +22 more
15citations -
Laparoscopic versus open resections in the posterosuperior liver segments within an enhanced recovery programme (ORANGE Segments): study protocol for a multicentre randomised controlled trial
Christoph Kuemmerli, Robert S. Fichtinger, Alma L. Moekotte, Luca Antonio Aldrighetti, Somaiah Aroori, Marc G. Besselink, +19 more
20citations -
Robotic Versus Laparoscopic Liver Resection: A Nationwide Propensity Score Matched Analysis2024 Annals of Surgery Open article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Gabriela Pilz da Cunha, Jasper P. Sijberden, Susan van Dieren, Paul D. Gobardhan, Daan J. Lips, Türkan Terkivatan, +25 more
18citations -
162TiP DEL-LIVER: An open-label, randomized phase II study of melphalan/HDS induction followed by standard therapy vs standard therapy alone in patients with liver-dominant refractory metastatic colorectal cancer
D. Arnold, C. Arslan, T. Wirth, J. Maurel, Michael Moche, K-K. Shiu, +12 more
0citations -
Perioperative rifaximin is not associated with enhanced functional and volumetric recovery after major liver resection2021 Scientific Reports article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Jan Bednarsch, Zoltán Czigány, Sven Heiko Loosen, Lara Rosaline Heij, Lorenz Ruckgaber, Henning Maes, +10 more
3citations -
Laparoscopic Versus Open Hemihepatectomy: The ORANGE II PLUS Multicenter Randomized Controlled Trial2024 Journal of Clinical Oncology article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Robert S. Fichtinger, Luca Antonio Aldrighetti, Mohammad Abu Hilal, Roberto Ivan TROISI, Robert Peter Sutcliffe, Marc G. Besselink, +47 more
86citations -
Laparoscopic versus open hemihepatectomy: a randomized controlled trial2022 Zeitschrift für Gastroenterologie article Medicine Hepatocellular Carcinoma Treatment and Prognosis
Robert S. Fichtinger, L. Aldrighetti, M. Abu Hilal, Roberto Ivan TROISI, Robert Suttcliffe, Marc G. Besselink, +13 more
0citations -
Laparoscopic versus open hemihepatectomy: does side matter? A post-hoc analysis of the ORANGE II PLUS randomized controlled trial2026 Surgical Endoscopy article Medicine Hepatocellular Carcinoma Treatment and Prognosis Open access
Bram Olij, Gabriela Pilz da Cunha, Francesca Ratti, Mohammad Abu Hilal, Roberto Ivan Troisi, Robert Peter Sutcliffe, +28 more
0citations